soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 PDF) Oral Semaglutide and Cardiovascular

& Gerken, G

For those interested in exploring options, you can learn more about vitamin b12 injections for energy and how they might fit into your wellness routine

460 Patients with T2DM complicated with the multivessel disease have a significantly higher risk of ischemic events and overall mortality than those with T2DM with single-vessel disease

(no photo available) 96 tests $948 CSB-EL018969HU Prostatic binding protein ELISA Kit (PBP), Human For quantitative detection in human samples

Lactobacillus rhamnosus GG ameliorates atherosclerosis via suppression of oxidative stress and inflammation by reshaping the gut microbiota